rtki cpd and Alloxan Diabetes

rtki cpd has been researched along with Alloxan Diabetes in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, J; Liang, G; Qian, Y; Wang, J; Weng, Q; Xu, Z; Zhao, Y; Zhong, P; Zou, C1
Hu, J; Li, X; Liang, D; Liang, G; Lin, F; Qian, Y; Wang, J; Xu, Z; Zeng, C; Zhong, P1
Akhtar, S; Al-Zaid, B; Attur, S; Benter, IF; Chandrasekhar, B; El-Hashim, AZ1
Akhtar, S; Almubrad, T; Benter, IF; Bron, AJ; Yousif, MH1
Gao, B; Gilbert, RE; Ingram, AJ; Kelly, DJ; Krepinsky, JC; Kumar, S; Peng, F; Wu, D; Zhang, B1
Akhtar, S; Benter, IF; Yousif, MH1
Akhtar, S; Benboubetra, M; Benter, IF; Griffiths, SM; Yousif, MH1

Other Studies

7 other study(ies) available for rtki cpd and Alloxan Diabetes

ArticleYear
EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress.
    Oncotarget, 2017, May-16, Volume: 8, Issue:20

    Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; ErbB Receptors; Humans; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Reactive Oxygen Species; Streptozocin; Transforming Growth Factor beta; Tyrphostins

2017
EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Journal of molecular and cellular cardiology, 2015, Volume: 82

    Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; ErbB Receptors; Fibrosis; Male; Mice; Myocardium; Oxidative Stress; Proto-Oncogene Proteins c-akt; Quinazolines; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Ventricular Remodeling

2015
Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney.
    International journal of pharmaceutics, 2016, Dec-05, Volume: 514, Issue:2

    Topics: Animals; Blood Glucose; Cyclic N-Oxides; Dendrimers; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; ErbB Receptors; Kidney; Male; MAP Kinase Signaling System; Phosphorylation; Quinazolines; Rats; Spin Labels; Tyrphostins

2016
Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes.
    Acta ophthalmologica, 2009, Volume: 87, Issue:8

    Topics: Animals; Collagen; Cornea; Corneal Stroma; Diabetes Mellitus, Experimental; Enzyme Inhibitors; ErbB Receptors; Female; Microscopy, Electron; Proteoglycans; Quinazolines; Rats; Rats, Wistar; Signal Transduction; Tissue Distribution; Tyrphostins

2009
EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen I upregulation in mesangial cells.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:3

    Topics: Animals; Blood Glucose; Cells, Cultured; Collagen Type I; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Estrenes; Female; Male; Mesangial Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phospholipase C gamma; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Pyrrolidinones; Quinazolines; Rats; Rats, Sprague-Dawley; RNA Interference; Tyrphostins; Up-Regulation

2009
The role of tyrosine kinase-mediated pathways in diabetes-induced alterations in responsiveness of rat carotid artery.
    Autonomic & autacoid pharmacology, 2005, Volume: 25, Issue:2

    Topics: Animals; Benzothiazoles; Body Weight; Carotid Arteries; Diabetes Mellitus, Experimental; Enzyme Inhibitors; ErbB Receptors; Female; Genes, erbB-1; Genes, erbB-2; Genistein; In Vitro Techniques; Protein-Tyrosine Kinases; Quinazolines; Rats; Rats, Wistar; Signal Transduction; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2005
Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
    British journal of pharmacology, 2005, Volume: 145, Issue:6

    Topics: Angiotensin II; Animals; Carbachol; Cell Line; Diabetes Mellitus, Experimental; Endothelin-1; ErbB Receptors; Female; Genistein; Histamine; Humans; In Vitro Techniques; Mesenteric Arteries; Mesenteric Veins; Norepinephrine; Quinazolines; Rats; Rats, Wistar; Signal Transduction; Streptozocin; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2005